By importing cGAMP from the TME, tumor cells that have a lower level of CIN or those with less cGAS expression can still activate the pro-tumor signaling downstream of STING, e.g. the noncanonical NF-κB pathway. The gene discussed is STING1; the disease is neoplasm.